Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $13
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Piper Sandler analyst David Amsellem maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $12 to $13.
Piper Sandler analyst David Amsellem maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $12 to $13.